{"id":40494,"date":"2026-05-15T12:56:37","date_gmt":"2026-05-15T16:56:37","guid":{"rendered":"https:\/\/www.bu.edu\/hic\/?post_type=profile&#038;p=40494"},"modified":"2026-05-28T09:22:54","modified_gmt":"2026-05-28T13:22:54","slug":"mark-grinstaff","status":"publish","type":"profile","link":"https:\/\/www.bu.edu\/hic\/profile\/mark-grinstaff\/","title":{"rendered":"Mark Grinstaff, PhD"},"content":{"rendered":"<p><span>Mark W. Grinstaff is the William Fairfield Warren Distinguished Professor of Boston University, and Professor of Translational Research, Biomedical Engineering, Chemistry, Materials Science and Engineering, and Medicine.\u00a0 He is also the Director of the NIH T32 Biomaterials Program and the Director of BU\u2019s Nanotechnology Innovation Center.<\/span><\/p>\n<p><span>Grinstaff&#8217;s awards include the ACS Nobel Laureate Signature Award, NSF Career Award, Pew Scholar in the Biomedical Sciences, Camille Dreyfus Teacher-Scholar, Alfred P. Sloan Research Fellowship, the Edward M. Kennedy Award for Health Care Innovation, and the Clemson Award for Applied Research. He is a Fellow of the American Institute of Medical and Biological Engineering, the American Academy of Nanomedicine, the American Institute of Chemists, the Biomedical Engineering Society, the Royal Chemical Society, the Royal Society of Medicine, the International Academy of Medical and Biological Engineering, the American Association for the Advancement of Science and a Founding Fellow of the National Academy of Inventors. <\/span><\/p>\n<p><span>Over the course of his tenure, Grinstaff\u2019s groundbreaking research has yielded more than 375 peer-reviewed publications, more than 200 patents and patent applications, and more than 325 oral presentations. His students and postdoctoral fellows have given more than 470 poster and 150 oral presentations at national and international conferences. His work has been cited more than 35,000 times. He is a co-founder of several companies and his innovative ideas and his efforts have also led to one new FDA approved pharmaceutical (Abraxane<\/span><sup>TM<\/sup><span>) and four medical device products (OcuSeal<\/span><sup>\u00ae<\/sup><span>\u00a0and Adherus Surgical Sealants<\/span><sup>\u00ae<\/sup><span>) that are now the standard of care. His current research activities involve the synthesis of new macromolecules and biomaterials, self-assembly chemistry, imaging contrast agents, drug delivery, and wound repair.<\/span><\/p>\n<p><a href=\"https:\/\/www.bumc.bu.edu\/camed\/profile\/mark-grinstaff\/\" target=\"_blank\" rel=\"noopener\">Website<\/a><\/p>\n<p><a href=\"https:\/\/scholar.google.com\/citations?hl=en&amp;user=x0ViSaoAAAAJ&amp;view_op=list_works&amp;sortby=pubdate\" target=\"_blank\" rel=\"noopener\">Google Scholar<\/a><\/p>\n","protected":false},"author":22836,"template":"","_links":{"self":[{"href":"https:\/\/www.bu.edu\/hic\/wp-json\/wp\/v2\/profile\/40494"}],"collection":[{"href":"https:\/\/www.bu.edu\/hic\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/www.bu.edu\/hic\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/hic\/wp-json\/wp\/v2\/users\/22836"}],"version-history":[{"count":7,"href":"https:\/\/www.bu.edu\/hic\/wp-json\/wp\/v2\/profile\/40494\/revisions"}],"predecessor-version":[{"id":40757,"href":"https:\/\/www.bu.edu\/hic\/wp-json\/wp\/v2\/profile\/40494\/revisions\/40757"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/hic\/wp-json\/wp\/v2\/media?parent=40494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}